Steven Cohen's position in Crinetics Pharmaceuticals is currently worth $23.3 Million. That's 0.06% of their equity portfolio (323rd largest holding). The first Crinetics Pharmaceuticals trade was made in Q3 2019. Since then Steven Cohen bought shares eleven more times and sold shares on eleven occasions. The stake costed the investor $21.7 Million, netting the investor a gain of 7.5% so far.